Introduction to Preformulation Studies
Preformulation is the very first investigative step in developing any new dosage form. Before a single tablet or injection is made, the raw drug substance must be thoroughly characterized — its crystal form, particle size, solubility across pH ranges, chemical stability against moisture and oxygen, and its BCS classification. This scientific profiling directly dictates every formulation decision: choice of excipients, manufacturing process, packaging, and shelf-life predictions.
Syllabus & Topics
- 1Introduction to Preformulation: The first learning phase of the drug development process. Goals: (1) Establish the physicochemical profile of the drug. (2) Identify potential problems. (3) Guide rational dosage form design. (4) Support regulatory filings.
- 2Physical Form – Crystalline vs Amorphous: Crystalline drugs have ordered lattice structures (sharp melting point, lower solubility, better stability). Amorphous drugs lack long-range order (no definite MP, higher solubility but less stable – may recrystallize during storage).
- 3Particle Size, Shape & Surface Area: Smaller particle size → ↑surface area → ↑dissolution rate (Noyes-Whitney equation). Measured by sieve analysis, microscopy, light scattering. Micronization (<10 µm) used for poorly soluble drugs (e.g., Griseofulvin).
- 4Flow Properties: Critical for uniform die filling during tablet compression. Measured by: Angle of Repose (≤30° = excellent flow), Carr’s Index (CI = (Tapped – Bulk)/Tapped × 100; <15% = good flow), Hausner Ratio (Tapped/Bulk; <1.25 = good flow). Poor flow → need glidants (Talc, Colloidal SiO₂).
- 5Solubility Profile: Intrinsic solubility (unionized form), pH-solubility profile (Henderson-Hasselbalch equation), effect of pKa (weak acids more soluble in alkaline pH; weak bases more soluble in acidic pH), Partition Coefficient (log P – determines membrane permeability and drug absorption).
- 6Polymorphism: The ability of a drug to exist in more than one crystalline form. Different polymorphs have different melting points, solubilities, dissolution rates, and bioavailabilities. Metastable polymorphs are more bioavailable but may convert to the stable form during storage (e.g., Chloramphenicol palmitate Polymorph A vs B).
- 7Solvates & Hydrates: Pseudopolymorphism — crystal lattice incorporates solvent molecules. Hydrates (water) are most common. Anhydrous forms are generally more soluble than hydrates (e.g., Ampicillin anhydrous vs trihydrate).
- 8Chemical Properties – Hydrolysis: Drugs with ester (-COO-) or amide (-NHCO-) bonds are susceptible to hydrolytic degradation by water. Accelerated by pH extremes. Prevention: minimize moisture, use anhydrous formulations, buffer to optimal pH.
- 9Chemical Properties – Oxidation: Drugs with phenols, catechols, thiols, or unsaturated bonds are prone to oxidative degradation via free radical chain reactions. Prevention: antioxidants (BHT, BHA, Ascorbic acid, Sodium metabisulfite), nitrogen purging, light-resistant packaging.
- 10Chemical Properties – Reduction, Racemisation, Polymerization: Reduction (gain of electrons – azo, nitro compounds). Racemisation (optical rotation change → loss of pharmacological activity, e.g., Adrenaline). Polymerization (rare – formaldehyde in PEG solutions).
- 11BCS Classification – Class I: High Solubility + High Permeability. Rapidly dissolve AND absorb. Rate-limiting step: gastric emptying. Examples: Metoprolol, Propranolol. Eligible for biowaivers.
- 12BCS Classification – Class II: Low Solubility + High Permeability. Dissolution is the rate-limiting step. Strategies: particle size reduction, solid dispersions, lipid formulations. Examples: Nifedipine, Ketoprofen.
- 13BCS Classification – Class III: High Solubility + Low Permeability. Permeation across gut membrane is rate-limiting. Strategies: permeation enhancers, absorption promoters. Examples: Ranitidine, Acyclovir.
- 14BCS Classification – Class IV: Low Solubility + Low Permeability. Most challenging for oral delivery. Both dissolution AND permeation are problems. Examples: Furosemide, Taxol. Often require IV administration.
Learning Objectives
Frequently Asked Questions (FAQs)
Q1. Why Is Preformulation Necessary Before Formulation Development?
Preformulation studies provide essential information about a drug’s physicochemical properties such as solubility, stability, polymorphic form, and particle characteristics. This information allows scientists to select suitable excipients, determine the appropriate dosage form (tablet, suspension, or injection), anticipate stability problems, and design proper packaging. Without this data, formulation development becomes largely trial-and-error, increasing development time and cost.
Q2. What Is Polymorphism and Why Does It Matter?
Polymorphism refers to the ability of a drug substance to crystallize in more than one crystal structure. Different polymorphs have different lattice energies, which can result in variations in melting point, solubility, dissolution rate, and bioavailability. A more soluble polymorph may improve drug absorption, while conversion to a less soluble stable form during storage can reduce effectiveness. A well-known example occurred with Ritonavir, where the appearance of a new polymorph required reformulation of the product.
Q3. What Is BCS and Why Is Class I Significant?
The Biopharmaceutics Classification System (BCS) classifies drugs into four categories based on aqueous solubility and intestinal permeability. Class I drugs have both high solubility and high permeability, allowing rapid dissolution and complete absorption. Because of this predictable behavior, regulatory agencies such as U.S. Food and Drug Administration and World Health Organization may grant biowaivers for Class I generic drugs, allowing in vitro dissolution testing instead of in vivo bioequivalence studies.
Q4. How Is Angle of Repose Used to Assess Powder Flow?
The angle of repose is measured by allowing powder to flow through a funnel onto a flat surface, forming a conical pile. The angle between the surface of the pile and the base represents the flowability of the powder. An angle ≤25° indicates excellent flow, 25–30° good flow, 30–40° fair flow, and >40° poor flow. Proper powder flow is important for uniform die filling during tablet compression.
Q5. What Is the Henderson–Hasselbalch Equation Used for in Preformulation?
The Henderson–Hasselbalch equation predicts the degree of ionization of weak acids and bases at a given pH. For weak acids: pH = pKa + log([A⁻]/[HA]); for weak bases: pH = pKa + log([B]/[BH⁺]). Since the unionized form of a drug crosses lipid membranes more readily, this equation helps determine the pH conditions under which a drug is most soluble and best absorbed.